[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1242443A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1242443A4
EP1242443A4 EP00990231A EP00990231A EP1242443A4 EP 1242443 A4 EP1242443 A4 EP 1242443A4 EP 00990231 A EP00990231 A EP 00990231A EP 00990231 A EP00990231 A EP 00990231A EP 1242443 A4 EP1242443 A4 EP 1242443A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990231A
Other languages
German (de)
English (en)
Other versions
EP1242443A1 (fr
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1242443A1 publication Critical patent/EP1242443A1/fr
Publication of EP1242443A4 publication Critical patent/EP1242443A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP00990231A 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides Withdrawn EP1242443A4 (fr)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US662191 1991-02-28
US47127599A 1999-12-23 1999-12-23
US471275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US488725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US552317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US598042 2000-07-09
US620312 2000-07-19
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US653450 2000-08-03
US65345000A 2000-08-31 2000-08-31
US66219100A 2000-09-14 2000-09-14
US69303600A 2000-10-19 2000-10-19
US693036 2000-10-19
US72734400A 2000-11-29 2000-11-29
WOPCT/US72/07344 2000-11-29
PCT/US2000/034263 WO2001053312A1 (fr) 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1242443A1 EP1242443A1 (fr) 2002-09-25
EP1242443A4 true EP1242443A4 (fr) 2005-06-22

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990231A Withdrawn EP1242443A4 (fr) 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides

Country Status (3)

Country Link
EP (1) EP1242443A4 (fr)
CA (1) CA2402563A1 (fr)
WO (1) WO2001053312A1 (fr)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2320625A1 (fr) 1998-02-09 1999-08-12 Human Genome Sciences, Inc. 45 proteines humaines secretees
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
PT1623989E (pt) * 1999-03-08 2007-09-25 Genentech Inc ''composições e métodos para o diagnóstico de tumores''
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2000073468A1 (fr) 1999-05-28 2000-12-07 Immunex Corporation Nouvelles kinases humaines et murines
EP1637541B1 (fr) * 1999-09-01 2010-03-03 Genentech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
EP2228446A1 (fr) * 1999-12-01 2010-09-15 Genentech, Inc. Polypeptides secrétés et transmembranaires et acides nucléiques codant pour ceux-ci
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
WO2001059080A1 (fr) 2000-02-11 2001-08-16 Millennium Pharmaceuticals, Inc. Proteine kinase 18477 et utilisations de celle-ci
US6479270B1 (en) 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
KR100811926B1 (ko) * 2000-02-17 2008-03-10 아방티 파르마 소시에테 아노님 파킨 유전자 활성의 조절에 유용한 조성물
JP2003525610A (ja) * 2000-03-02 2003-09-02 キュラゲン コーポレイション 熱応答に関連する遺伝子ｇ１２ｌ
US6569667B1 (en) 2000-04-26 2003-05-27 Millennium Pharmaceuticals, Inc. 26335, a novel human serine/threonine dehydratase and uses thereof
WO2002000859A2 (fr) * 2000-06-23 2002-01-03 Millennium Pharmaceuticals, Inc. 46508 nouveau membre humain de la famille des peptidyl-arnt hydrolases et ses utilisations
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
MXPA02009481A (es) * 2000-03-31 2004-05-14 Aventis Pharma Inc Factor inductor del factor nuclear kb.
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
WO2001079467A2 (fr) * 2000-04-12 2001-10-25 The United States Of America, As Represented By Secretary Of The Department Of Health & Human Services Identification d'une nouvelle nadph-oxydase renale
AU5542101A (en) * 2000-04-14 2001-10-30 Univ Vanderbilt Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US20020123097A1 (en) * 2000-09-19 2002-09-05 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
US6461846B2 (en) 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (de) * 2000-05-31 2001-12-13 Schering Ag Humanes PEM als Target für die Fertilitätskontrolle
WO2001094413A2 (fr) 2000-06-06 2001-12-13 Bristol-Myers Squibb Company Acides nucleiques et polypeptides apparentes a b7 utiles pour effectuer une immunomodulation
AU2001268570A1 (en) * 2000-06-16 2001-12-24 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
FR2810673B1 (fr) * 2000-06-26 2004-10-08 Univ Toulouse Dynamine mitochondriale humaine msp1 et son utilisation en therapeutique
AU2001273148A1 (en) 2000-06-30 2002-01-14 Millennium Pharmaceuticals, Inc. 57658, a human uridine kinase and uses thereof
WO2002006331A2 (fr) * 2000-07-18 2002-01-24 Millennium Pharmaceuticals, Inc. 14087, nouvelle molecule de serine protease, et utilisations associees
WO2002008282A2 (fr) * 2000-07-26 2002-01-31 Stanford University Proteine bstp-ras/rerg et reactifs apparentes, procedes d'utilisation de ces derniers
EP1307553A2 (fr) * 2000-08-01 2003-05-07 Oregon Health & Science University Gene codant pour des proteines d'enveloppe se liant a l'adn mammalien et utilisations dudit gene
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
JP2004510415A (ja) * 2000-08-03 2004-04-08 インサイト・ゲノミックス・インコーポレイテッド インテグリン
ES2269430T3 (es) * 2000-08-04 2007-04-01 Ludwig Institute For Cancer Research Gen supresor.
WO2002018578A2 (fr) 2000-08-28 2002-03-07 Agensys, Inc. Acide nucleique et proteine correspondante denommes 85p1b3 utilises dans le traitement et la detection de cancers
WO2002018566A2 (fr) * 2000-08-31 2002-03-07 Bayer Aktiengesellschaft Regulation d'enzyme de type l-asparaginase humaine
AU2001287448A1 (en) 2000-09-01 2002-03-13 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
AU2001292561A1 (en) * 2000-09-01 2002-03-13 Hyseq, Inc. Nucleic acids and polypeptides
IL154962A0 (en) * 2000-09-27 2003-10-31 Millennium Pharm Inc Potassium channel interactors and uses therefor
AU2001293830A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
AU2001293846A1 (en) * 2000-09-28 2002-04-08 Bayer Aktiengesellschaft Regulation of a human serine protease
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
CA2425396A1 (fr) * 2000-11-07 2002-06-13 Board Of Regents, The University Of Texas System Methodes et compositions associees aux proteines fixant la calcineurine sarcomerique specifique aux muscles (calsarcines)
WO2002081703A2 (fr) * 2000-11-16 2002-10-17 Emory University Regulateurs d'oxygenase mitogeniques
WO2002040651A2 (fr) * 2000-11-17 2002-05-23 Bayer Aktiengesellschaft Regulation de l'adenosine desaminase humaine specifique a arnt
EP1209229A1 (fr) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gène impliqué dans la schizophrénie
WO2002046228A2 (fr) * 2000-12-05 2002-06-13 Wisconsin Alumni Research Foundation Recepteur de la toxine du b. anthracis
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JPWO2002050269A1 (ja) * 2000-12-21 2004-04-22 株式会社ジェノックス創薬研究所 アレルギー性疾患の検査方法
AU2002249876A1 (en) * 2000-12-22 2002-08-19 Millennium Pharmaceuticals, Inc. 25828, a novel human aminopeptidase and uses therefor
WO2002053716A2 (fr) * 2001-01-03 2002-07-11 Bayer Aktiengesellschaft Regulation de l'ornithine decarboxylase humaine
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
CA2406342A1 (fr) 2001-01-22 2002-07-25 Shinae Kondoh Genes associes a l'apoptose humaine et proteines produites associees a l'apoptose humaine
WO2002076174A2 (fr) * 2001-01-22 2002-10-03 Millennium Pharmaceuticals, Inc. Fbh58295fl, nouveau transporteur d'acide amine humain et utilisations associees
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
EP1358326A2 (fr) * 2001-02-09 2003-11-05 Incyte Genomics, Inc. Proteines associees a la croissance, a la differenciation et a la mort cellulaire
WO2002064777A2 (fr) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteines 7b6 et 11b4 et sequences d'adn codant pour celles-ci
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
AU2002250151B2 (en) 2001-02-16 2007-08-16 Bristol-Myers Squibb Company Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
US6461843B1 (en) * 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
AU2002258520A1 (en) * 2001-03-16 2002-10-03 Incyte Genomics, Inc. Nucleic acid-associated proteins
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
WO2002077219A1 (fr) * 2001-03-26 2002-10-03 Lexicon Genetics Incorporated Nouvelles asparaginases humaines et polynucleotides codant ces dernieres
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
US20020169127A1 (en) 2001-03-29 2002-11-14 Charmley Patrick R. Compositions and methods for diagnosing or treating psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
WO2002083887A2 (fr) * 2001-04-12 2002-10-24 Bayer Aktiengesellschaft Regulation de la proteine de type methionine aminopeptidase humaine
EP1258495A1 (fr) * 2001-05-09 2002-11-20 Millennium Pharmaceuticals, Inc. 98359, Sous unité beta 4 du canal sodique, et ses applications
WO2002097093A1 (fr) * 2001-05-30 2002-12-05 Chiba-Prefecture Acides nucleiques isoles dans le neuroblastome
WO2003004608A2 (fr) * 2001-07-06 2003-01-16 Incyte Genomics, Inc. Enzymes de metabolisation de medicaments
US20040219551A1 (en) * 2001-07-09 2004-11-04 Petersen Ole William Epsti1, a novel gene induced by epithelial-stromal interaction in human breast cancer
AU2002321768B2 (en) * 2001-07-26 2008-03-06 Serono Genetics Institute S.A. GMG-2 polynucleotides and polypeptides and uses thereof
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
FR2828209A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a domaine hect, leurs utilisations en diagnostics et en therapie
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
US7262026B2 (en) 2001-08-23 2007-08-28 Japan Science And Technology Agency Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
JP2003135063A (ja) * 2001-08-24 2003-05-13 Chiba Prefecture 新規な遺伝子ｎｅｄｌ−１
JP4625633B2 (ja) * 2001-08-27 2011-02-02 独立行政法人科学技術振興機構 細胞移動調節及び細胞死調節機能を有するタンパク質
EP1427842A4 (fr) * 2001-08-31 2005-06-15 Millenium Pharmaceuticals Inc Mid 9002, membre de la famille des sulfatases humaines, et utilisations correspondantes
AU2002330015B2 (en) 2001-09-18 2008-02-07 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2008202000A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP4232423B2 (ja) * 2001-09-28 2009-03-04 第一三共株式会社 新規ユビキチン特異プロテアーゼ
CA2462644A1 (fr) * 2001-10-03 2003-04-10 Immunex Corporation Polypeptides des cytokines humaine et murine
WO2003038093A2 (fr) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation de la l-serine deshydratase humaine
US20030124593A1 (en) * 2001-10-31 2003-07-03 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
AU2002358267A1 (en) * 2001-12-19 2003-07-09 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
WO2003057867A2 (fr) * 2002-01-10 2003-07-17 Bayer Healthcare Ag Regulation de l'enzyme de liaison a l'amp, du type coa ligase d'acide gras humaine
AU2003235632A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060110A2 (fr) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation d'enzyme de liaison amp du type coa ligase d'acides gras humains
AU2003205174A1 (en) * 2002-01-17 2003-09-02 Incyte Genomics, Inc. Molecules for disease detection and treatment
AU2003227179A1 (en) * 2002-02-08 2003-09-09 Amersham Biosciences K.K. Fused protein having glucuronyl transferase activity
JP2003250550A (ja) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd 脂肪細胞分化関連遺伝子およびタンパク質
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US20050244825A1 (en) * 2002-03-27 2005-11-03 Bayer Healthcare Ag Regulation of human bmp-2 inducible kinase
EP1492871A2 (fr) * 2002-03-28 2005-01-05 QLT Inc. Proteines kinases associees au cancer et leurs utilisations
CA2480386A1 (fr) * 2002-03-29 2003-10-09 National Institute Of Advanced Industrial Science And Technology Nouvelles galactose transferases et leurs peptides, et acide nucleique codant pour lesdites transferases
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
NZ535925A (en) * 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
WO2003093826A2 (fr) * 2002-04-29 2003-11-13 Clinigenetics Dosages permettant d'identifier des molecules hypocholesterolemiantes
US7009038B2 (en) 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
EP2269628A3 (fr) 2002-05-29 2011-04-20 DeveloGen Aktiengesellschaft Proteines specifiques du pancreas
WO2003104459A1 (fr) * 2002-06-07 2003-12-18 Arthron Limited Modele animal transgenique de fc$g(g)riia pour affection auto-immune
MXPA04012560A (es) * 2002-06-13 2005-10-19 Wyeth Corp Inhibidores de la actividad genica inflamatoria y biosintesis de colesterol.
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
WO2004002514A1 (fr) * 2002-06-26 2004-01-08 Takeda Pharmaceutical Company Limited Substances destinees a la prevention et/ou au traitement du cancer
US20060110384A1 (en) * 2002-07-10 2006-05-25 Yuji Matsuzawa Novel proteins and use thereof
JP2004097199A (ja) * 2002-07-15 2004-04-02 Keio Gijuku 腫瘍抗原のスクリーニング方法
AU2003281515A1 (en) * 2002-07-19 2004-02-09 Cellzome Ag Protein complexes of cellular networks underlying the development of cancer and other diseases
AU2003254081A1 (en) * 2002-07-24 2004-02-09 New York University Truncated rgr in t cell malignancy
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
WO2004013320A1 (fr) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation de la methyltransferase humaine
AU2003266271A1 (en) * 2002-08-13 2004-03-19 Bayer Healthcare Ag Regulation of human esterase
EP1532276A2 (fr) * 2002-08-28 2005-05-25 EVOTEC Neurosciences GmbH Utilisation de polynucleotides et de polypeptides du gene foap-13 pour le diagnostic et la therapie de maladies neurodegeneratives
EP1396544A1 (fr) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Acides nucléiques codant pour des déhydrogénases thyroidiennes humaines
CA2498739A1 (fr) * 2002-09-12 2004-03-25 Pharmexa A/S Immunisation contre la ghreline autologue
EP1556484A2 (fr) * 2002-09-13 2005-07-27 Ingenium Pharmaceuticals AG Genes de la chaine lourde 1 de dyneine cytoplasmiques, produits d'expression, modele animal non humain : utilisation pour les maladies neurologiques humaines
AU2003266605A1 (en) * 2002-09-27 2004-04-19 Takeda Pharmaceutical Company Limited Preventives/remedies for neurodegenerative disease
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
WO2004039980A1 (fr) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Methodes de traitement et compositions
WO2004039974A1 (fr) * 2002-10-30 2004-05-13 Takeda Pharmaceutical Company Limited Nouvelle proteine et son adn
US7060797B2 (en) * 2002-11-21 2006-06-13 Wyeth Composition and method for treating lupus nephritis
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
DE60336015D1 (de) * 2002-12-24 2011-03-24 Univ Beijing Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon
WO2004094617A2 (fr) * 2003-02-21 2004-11-04 Phenomix Corporation Polypeptides de sensin, acides nucleiques les codant, mutations associees, et methodes destinees a leur identification et utilisation
EP1602666A4 (fr) * 2003-03-10 2006-05-24 Takeda Chemical Industries Ltd Nouvelle proteine et son adn
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (fr) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Protéine associée à la distrophine (Drop1) utilisée comme marqueur por le cancer
US7829682B1 (en) 2003-04-30 2010-11-09 Incyte Corporation Human β-adrenergic receptor kinase nucleic acid molecule
CN1244595C (zh) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 一种肿瘤抑制蛋白及其应用
ES2348008T3 (es) * 2003-06-18 2010-11-26 Chugai Seiyaku Kabushiki Kaisha Transportador de fucosa.
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
WO2004113532A1 (fr) * 2003-06-21 2004-12-29 Shigeki Higashiyama Proteine pouvant cribler un agent cytostatique, procede de criblage d'un agent cytostatique et agent cytostatique
WO2005003336A2 (fr) * 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Choline-phosphotransferases et ethanolamine-phosphotransferases nouvellement identifiees
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
WO2005030241A2 (fr) * 2003-09-23 2005-04-07 Meyer Pharmaceuticals, Llc Traitement d'une inflammation au moyen d'un agent biologique provoquant la liberation de recepteurs de cytokines par des cellules
JP2005168338A (ja) * 2003-12-09 2005-06-30 Japan Science & Technology Agency 新規タンパク質カルフォグリン、これをコードする遺伝子、薬剤、及び標的物質
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005090574A1 (fr) * 2004-03-19 2005-09-29 Genomidea Inc. Gène inhibant le développement endothélial vasculaire
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
ATE479778T1 (de) * 2004-09-24 2010-09-15 Oncotherapy Science Inc Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8
CN101068936A (zh) * 2004-11-22 2007-11-07 惠氏公司 用于实体瘤预后及治疗的方法和系统
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
JP5109131B2 (ja) 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
EP1734118A1 (fr) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Identification de gènes modulateurs de la voie de signalisation JAK/STAT par criblage du génome à l'aide d'ARNi
WO2007028631A1 (fr) * 2005-09-09 2007-03-15 H. Lundbeck A/S Facteur de risque genetique de troubles neurodeveloppementaux et leurs complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
US20090305255A1 (en) * 2006-02-01 2009-12-10 Hiroshima University Substrate Protein for M-Phase Kinase and use Thereof
EP1815863A1 (fr) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Utilisation des agopistes TLR3 pour le traitement des maladies neurodégénératives
WO2007095113A2 (fr) 2006-02-10 2007-08-23 Massachusetts Institute Of Technology Composés et inhibiteurs de cpg15 et cpg15-2 comme agonistes et antagonistes du récepteur de l'insuline et des récepteurs des facteurs de croissance analogues à l'insuline
US8933209B2 (en) * 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
WO2008106640A1 (fr) 2007-03-01 2008-09-04 Cedars-Sinai Medical Center Polymères antioxydants contenant des fragments [1,2]-dithiolane et leurs utilisations
US8664359B2 (en) * 2007-06-03 2014-03-04 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (fr) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouveau facteur de viabilité neuronale et son utilisation
US9028874B2 (en) 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
KR20100124326A (ko) 2008-03-14 2010-11-26 엑사젠 다이어그노스틱스, 인코포레이티드 염증성 장 질병 및 과민성 장 증후군에 대한 생체마커
EP2300451A1 (fr) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Promédicaments de dimension nanométrique de nsaids
WO2010060098A1 (fr) 2008-11-24 2010-05-27 Cedars-Sinai Medical Center Dérivés antioxydants de la camptothécine et leurs nanosphères antioxydantes antinéoplasiques
SG10201402493UA (en) 2009-02-20 2014-10-30 Ganymed Pharmaceuticals Ag Methods and compositions for diagnosis and treatment of cancer
ES2649389T3 (es) 2009-11-11 2018-01-11 Ganymed Pharmaceuticals Gmbh Anticuerpos específicos para claudina 6 (CLDN6)
EP2404936A1 (fr) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Thérapie du cancer utilisant des anticorps in vivo dirigés sur la cible CLDN6
ES2565063T3 (es) 2011-05-13 2016-03-31 Ganymed Pharmaceuticals Ag Anticuerpos para el tratamiento de un cáncer que expresa la claudina 6
DK2711017T3 (en) * 2011-05-19 2016-11-07 Toray Industries Immunity-inducing agent
WO2013104798A1 (fr) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulateurs de réponses immunitaires
WO2013120554A1 (fr) 2012-02-15 2013-08-22 Novo Nordisk A/S Anticorps qui se lient à la protéine 1 de reconnaissance de peptidoglycane
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
NO2814844T3 (fr) 2012-02-15 2017-12-30
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (fr) 2013-07-31 2015-02-05 Biontech Ag Diagnostic et thérapie du cancer impliquant des cellules souches cancéreuses
DK3172232T5 (da) 2014-07-17 2024-10-14 Novo Nordisk As Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
EP2977758A1 (fr) * 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Procédés et kits pour surveiller la néphropathie membraneuse
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
CA2971402C (fr) 2014-12-19 2023-08-01 F. Hoffmann-La Roche Ag Transglutaminases microbiennes, substrats pour celles-ci et procedes pour les utiliser
CA2971246C (fr) 2014-12-19 2020-07-14 F. Hoffmann-La Roche Ag Identification de substrats de transglutaminase et leurs utilisations
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
PE20181897A1 (es) 2016-04-21 2018-12-11 Immatics Biotechnologies Gmbh Inmunoterapia contra el melanoma y otros tipos de cancer
CR20200607A (es) 2016-04-21 2021-01-20 Immatics Biotechnologies Gmbh INMUNOTERAPIA CONTRA EL MELANOMA Y OTROS TIPOS DE CÁNCER (Divisional 2018-551)
AU2019248547A1 (en) 2018-04-02 2020-09-10 Bristol-Myers Squibb Company Anti-TREM-1 antibodies and uses thereof
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
WO2021173847A1 (fr) * 2020-02-27 2021-09-02 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Cobra1/nelf-b utilisé en tant que renforçateur d'efficacité d'une thérapie à base de lymphocytes t cd8+

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (fr) * 1998-03-10 1999-09-16 Genentech, Inc. Nouveaux polypeptides et acides nucleiques les codant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (fr) * 1998-03-10 1999-09-16 Genentech, Inc. Nouveaux polypeptides et acides nucleiques les codant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004570106, ISSN: 0378-1119 *
See also references of WO0153312A1 *

Also Published As

Publication number Publication date
WO2001053312A8 (fr) 2002-06-20
CA2402563A1 (fr) 2001-07-26
EP1242443A1 (fr) 2002-09-25
WO2001053312A1 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1239039A4 (fr) Nouveau polypeptide et son adn
AU3511100A (en) Novel nucleic acids and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
AU1453601A (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/11 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 07K 14/435 B

Ipc: 7C 12N 15/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060111